Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in LLY — ELI LILLY & Co

CIK 873630 LONDON, X0
Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,385,180,690
+$669,176,848 QoQ
Shares Held
1,988,595
+6.6% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#45
of 4,632 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Jun 30, 2026
CallValue
$34,543,586
CallShares
28,800
PutValue
$166,720,783
PutShares
139,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $8,561,718,221 across 13 Drug Manufacturers - General names. LLY ranks #1 (27.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page 		1,988,595 $2,385,180,690
2 JNJ
Johnson & Johnson
 9,006,497 $2,287,380,035
3 ABBV
AbbVie Inc.
 4,131,637 $1,039,685,126
4 MRK
Merck & Co., Inc.
 7,734,965 $993,943,001
5 AMGN
Amgen Inc
 1,385,321 $501,652,433
6 GILD
Gilead Sciences, Inc.
 3,836,489 $484,702,016
7 PFE
Pfizer Inc
 16,704,156 $402,236,070
8 BMY
Bristol Myers Squibb Co
 5,409,898 $311,718,319

All Filings in LLY

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,385,180,690 1,988,595
2026-06-30 $34,543,586 28,800
2026-06-30 $166,720,783 139,000
2026-03-31 $23,822,043 25,900
2026-03-31 $1,716,003,842 1,865,688
2026-03-31 $30,444,387 33,100
2025-12-31 $45,781,371 42,600
2025-12-31 $57,495,385 53,500
2025-12-31 $2,132,762,828 1,984,556
2025-09-30 $1,441,599,992 1,889,384
2025-09-30 $29,375,500 38,500
2025-06-30 $935,436 1,200
2025-06-30 $31,882,777 40,900
2025-06-30 $1,555,368,914 1,995,265
2025-03-31 $1,761,819,638 2,133,186
2025-03-31 $41,295,500 50,000
2025-03-31 $41,212,909 49,900
2024-12-31 $38,831,600 50,300
2024-12-31 $1,607,388,920 2,082,110
2024-12-31 $4,786,400 6,200
2024-09-30 $13,023,318 14,700
2024-09-30 $21,616,936 24,400
2024-09-30 $1,907,514,745 2,153,097
2024-06-30 $2,064,081,694 2,279,796
2024-06-30 $13,218,548 14,600
2024-06-30 $37,844,884 41,800
2024-03-31 $36,953,100 47,500
2024-03-31 $6,690,456 8,600
2024-03-31 $1,700,479,742 2,185,819
2023-12-31 $22,325,836 38,300
2023-12-31 $1,019,324,802 1,748,653
2023-12-31 $2,098,512 3,600
2023-09-30 $811,062,536 1,509,993
2023-09-30 $84,866 158
2023-09-30 $3,276,493 6,100
2023-06-30 $3,095,268 6,600
2023-06-30 $646,823,777 1,379,214
2023-03-31 $68,684 200
2023-03-31 $432,979,124 1,260,786
2022-12-31 $502,903,779 1,374,655
2022-12-31 $7,316,800 20,000
2022-12-31 $292,672 800
2022-09-30 $6,467,000 20,000
2022-09-30 $284,744,593 880,608
2022-09-30 $259,000 800
2022-06-30 $6,484,600 20,000
2022-06-30 $259,000 800
2022-06-30 $343,556,373 1,059,607
2022-03-31 $261,358,727 912,661
2022-03-31 $229,000 800